SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Han All Pharmaceutical Co., Ltd. Receives Issue Notification from the U.S. Patent and Trademark Office for its lead Hanferon(TM) (Protease resistant Interferon-alpha) Molecule